2 days ago · Check Out Our Latest Stock Report on SPRY ARS Pharmaceuticals Stock Up 1.1 %. Shares of NASDAQ:SPRY traded up $0.08 during trading on Wednesday, hitting $7.43. 103,051 shares of the company traded hands, compared to its average volume of 802,477. The business's fifty day moving average is $6.98 and its 200-day moving average is $7.02. Sep 8, 2023 · Based on short-term price targets offered by two analysts, the average price target for ARS Pharmaceuticals, Inc. comes to $14.00. The forecasts range from a low of $13.00 to a high of $15.00. The ... ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops treatments for patients and parents affected by severe allergic reactions. It is developing neffy, a needle-free and low-dose intranasal epinephrine nasal spray for patients and their caregivers with type I allergic reactions, including anaphylaxis.Find the latest SPDR S&P 500 ETF Trust (SPY) stock quote, history, news and other vital information to help you with your stock trading and investing. Sep 1, 2023 · After registering a 10.16% upside in the latest session, ARS Pharmaceuticals Inc. (SPRY) has traded red over the past five days. The stock hit a weekly high of 8.00 this Thursday, 08/31/23, jumping 10.16% in its intraday price action. The 5-day price performance for the stock is 12.54%, and 11.57% over 30 days. SPRY Earnings Date and Information. ARS Pharmaceuticals last released its quarterly earnings results on August 10th, 2023. The reported ($0.18) EPS for the quarter, missing analysts' consensus estimates of ($0.17) by $0.01. The business earned $0.01 million during the quarter.SPRY support price is $6.65 and resistance is $7.15 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SPRY stock will trade within this expected range on the day.Corporate insiders are often awarded stock options as part of their compensation packages; this gives them the right to buy shares at a set price for a finite period. When an insider buys stocks because they are receiving a grant of shares for retention purposes, the Buy does not reveal what they think about the company’s prospects. SPYR | Complete SPYR Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Aug 31, 2023 · According to 3 analysts, the average rating for SPRY stock is "Buy." The 12-month stock price forecast is $14.5, which is an increase of 96.74% from the latest price. Laura Shawver Sells 73,059 Shares of ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) Stock marketbeat.com - June 2 at 10:47 PM: Q2 2023 Earnings Estimate for ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) Issued By Wedbush marketbeat.com - May 22 at 1:27 AM: Wedbush Keeps Their Buy Rating on ARS Pharmaceuticals (SPRY) markets.businessinsider.com - May 18 at 7 ...May 9, 2023 · On May 9, 2023, SPRY stock had a median target price of $17.00, representing a significant increase of 227.87% from the last price of $5.19. The current consensus among three polled investment analysts is to buy stock in ARS Pharmaceuticals Inc. The earnings per share for SPRY stock were -$0.16, and the sales were $0.00 for the current quarter. ARS Pharmaceuticals, Inc. (SPRY) NasdaqGM - NasdaqGM Real Time Price. Currency in USD. Follow. 7.37 +0.05 (+0.68%) At close: 04:00PM EDT. 7.45 +0.08 (+1.09%) After hours: 06:33PM EDT. 1d. May 22, 2023 · You can check out the most recent news articles about ARS Pharmaceuticals Inc (SPRY) by visiting AAII Stock Evaluator. Relative Price Strength of ARS Pharmaceuticals Inc. Relative price strength addresses the relationship between a stock price’s trend and the price trend of the market. Sep 1, 2023 · ARS Pharmaceuticals GAAP EPS of -$0.87 beats by $0.45, revenue of $1.32M beats by $0.05M. SA NewsThu, Mar. 23. kekkyoku sonna kimi ga sukimartinica May 10, 2023 · SPRY Stock Analysis: Fluctuations, Market Cap, and Earnings Growth in the Health Technology Sector The market cap of SPRY is $599.3M, indicating that it is a mid-cap company. The company’s earnings growth rate over the past year was 66.12%, while this year’s earnings growth rate is 21.84%. Sep 1, 2023 · After registering a 10.16% upside in the latest session, ARS Pharmaceuticals Inc. (SPRY) has traded red over the past five days. The stock hit a weekly high of 8.00 this Thursday, 08/31/23, jumping 10.16% in its intraday price action. The 5-day price performance for the stock is 12.54%, and 11.57% over 30 days. Discover historical prices for SPRY stock on Yahoo Finance. View daily, weekly or monthly format back to when ARS Pharmaceuticals, Inc. stock was issued. ... ARS Pharmaceuticals, Inc. (SPRY ... Wedbush Trims ARS Pharmaceuticals' PT to $15 From $17, Adjusts US, EU Launch Estimates, Lowers Peak Penetration for neffy/Anaphylaxis in US; Keeps Outperform Rating. Jun. 21. MT. Wedbush Initiates ARS Pharmaceuticals at Outperform With $10 PT, Says Neffy Intranasal Spray Set to Shake Up Epinephrine Market. Jan. 31.Get the latest ARS Pharmaceuticals Inc (SPRY) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. While the F1 consensus estimate and revision is a key driver of stock prices, the Q1 consensus is an important item as well, especially over the short-term, and particularly as a stock approaches ...Jul 20, 2023 · ARS Pharmaceuticals Stock (NASDAQ:SPRY) Dividends Historical and Upcoming ARS Pharmaceuticals Dividends. The table below includes dividend amounts, payment dates and ex-dividend dates for ARS ... Laura Shawver Sells 73,059 Shares of ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) Stock marketbeat.com - June 2 at 10:47 PM: Q2 2023 Earnings Estimate for ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) Issued By Wedbush marketbeat.com - May 22 at 1:27 AM: Wedbush Keeps Their Buy Rating on ARS Pharmaceuticals (SPRY) markets.businessinsider.com - May 18 at 7 ...SPRY, The start of multi day / week breakout has commenced. SPRY has gained +77.88% last trading day due to FDA conveying benefits of their epinephrine nasal spray -- and a possible commercial approval on a scheduled date. Investors confidence were UP reflecting the massive price surge last May 11. Nov 22, 2022 · As of 2023 July 13, Thursday current price of SPRY stock is 6.680$ and our data indicates that the asset price has been in an uptrend for the past 1 year (or since its inception). ARS Pharmaceuticals stock price as been showing a rising tendency so we believe that similar market segments were very popular in the given time frame. Find the latest SPYR, Inc. (SPYR) stock quote, history, news and other vital information to help you with your stock trading and investing.ARS Pharmaceuticals Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time SPRY stock price. On May 9, 2023, SPRY stock had a median target price of $17.00, representing a significant increase of 227.87% from the last price of $5.19. The current consensus among three polled investment analysts is to buy stock in ARS Pharmaceuticals Inc. The earnings per share for SPRY stock were -$0.16, and the sales were $0.00 for the current quarter. watch elf film Complete ARS Pharmaceuticals Inc. stock information by Barron's. View real-time SPRY stock price and news, along with industry-best analysis.Sep 1, 2023 · ARS Pharmaceuticals GAAP EPS of -$0.87 beats by $0.45, revenue of $1.32M beats by $0.05M. SA NewsThu, Mar. 23. SPYR, Inc. is a holding company, which engages in the development and resell of Apple compatible products with an emphasis on the smart home market. It also identifies and acquires companies ... Get the latest ARS Pharmaceuticals Inc (SPRY) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Aug 23, 2023 · Price Performance Review of SPRY. On Tuesday, ARS Pharmaceuticals Inc. [NASDAQ:SPRY] saw its stock jump 0.29% to $7.03. On the same session, the stock had its day’s lowest price of $6.99, but rose to a high of $7.54. Over the last five days, the stock has lost -0.14%. ARS Pharmaceuticals Inc. shares have fallen nearly -17.58% since the year ... Sep 12, 2023 · SPRY Overview Stock Screener Earnings Calendar Sectors Nasdaq | SPRY U.S.: Nasdaq ARS Pharmaceuticals Inc. Watch list Open Last Updated: Sep 1, 2023 11:23 a.m. EDT Real time quote $ 7.65 0.56... Discover historical prices for SPRY stock on Yahoo Finance. View daily, weekly or monthly format back to when ARS Pharmaceuticals, Inc. stock was issued. ... ARS Pharmaceuticals, Inc. (SPRY ...Complete ARS Pharmaceuticals Inc. stock information by Barron's. View real-time SPRY stock price and news, along with industry-best analysis. See the latest ARS Pharmaceuticals Inc stock price (NASDAQ:SPRY), related news, valuation, dividends and more to help you make your investing decisions.ARS Pharmaceuticals, Inc. (SPRY) NasdaqGM - NasdaqGM Real Time Price. Currency in USD. Follow. 7.37 +0.05 (+0.68%) At close: 04:00PM EDT. 7.45 +0.08 (+1.09%) After hours: 06:33PM EDT. 1d. devils fork state park Find the latest Ocean Spray Cranberries, Inc. PFD 4% (OCESP) stock quote, history, news and other vital information to help you with your stock trading and investing. Sep 1, 2023 · Ars Pharmaceuticals stock was originally listed at a price of $25.00 in Dec 4, 2020. If you had invested in Ars Pharmaceuticals stock at $25.00, your return over the last 2 years would have been -71.56%, for an annualized return of -46.67% (not including any dividends or dividend reinvestments). How much is Ars Pharmaceuticals's stock price per ... While the F1 consensus estimate and revision is a key driver of stock prices, the Q1 consensus is an important item as well, especially over the short-term, and particularly as a stock approaches ...May 10, 2023 · As of Wednesday, May 10, ARS Pharmaceuticals Inc’s SPRY share price has dipped by 12.23%, which has investors questioning if this is right time to buy. Premium Products Basic Membership Access to Journal, Shadow Stock portfolio & monthly updates for stock screens ARS Pharmaceuticals Inc. 500 Fairview Avenue North. Suite 600. Seattle, Washington 98109. Phone 1 206 456-2900. Industry Biotechnology. Sector Health Care/Life Sciences. Market Capitalization. $704.35 million. P/E Ratio. N/A. Dividend Yield. N/A. Price Target. $15.33. Profile Analyst Ratings Chart Competitors Earnings Financials Insider Trades Institutional Ownership Headlines Options Chain SEC Filings Short Interest Social Media.Latest ARS Pharmaceuticals Inc Stock News. As of September 01, 2023, ARS Pharmaceuticals Inc had a $677.6 million market capitalization, putting it in the 59th percentile of companies in the Biotechnology & Medical Research industry. ARS Pharmaceuticals Inc does not have a meaningful P/E due to negative earnings over the last 12 trailing months.Aug 31, 2023 · According to 3 analysts, the average rating for SPRY stock is "Buy." The 12-month stock price forecast is $14.5, which is an increase of 96.74% from the latest price. 2 days ago · See the latest ARS Pharmaceuticals Inc stock price (NASDAQ:SPRY), related news, valuation, dividends and more to help you make your investing decisions. ARS is currently developing a needle-free nasal spray designed to consistently deliver a pharmacodynamic exposure of epinephrine that is similar to existing treatments. Our nasal spray may help reduce hesitation and allow patients to confidently administer when needed. Patient and Caregiver preparedness to act quickly and confidently during a ...Aug 31, 2023 · Analyzing SPRY Stock Performance. On Wednesday, ARS Pharmaceuticals Inc. [NASDAQ: SPRY] rose 0.28% to $7.11. The stock’s lowest price that day was $7.00, but it reached a high of $7.235 in the same session. During the last five days, there has been a surge of approximately 1.72%. The AAII Stock Evaluator puts a company’s grades, charts, news, financials, valuation, ratios, filings and more at your fingertips. ARS Pharmaceuticals Inc’s Stock Price as of Market Close. As of May 04, 2023, 4:00 PM CST, ARS Pharmaceuticals Inc’s stock price was $6.12.Price Performance Review of SPRY. On Tuesday, ARS Pharmaceuticals Inc. [NASDAQ:SPRY] saw its stock fall -1.74% to $7.35. On the same session, the stock had its day’s lowest price of $7.31, but rose to a high of $7.54. Over the last five days, the stock has gained 3.81%. ARS Pharmaceuticals Inc. shares have fallen nearly -13.83% since the year ...Employees: 90. 11682 EL CAMINO REAL, SUITE 120, SAN DIEGO, CA, 92130. 858-771-9307. ars-pharma.com. ARS Pharmaceuticals, Inc. develops ARS-1, a novel intranasal epinephrine spray with absorption technology for patients and their families at-risk of severe allergic reactions to food, medications, and insect bites. SVB Securities analyst Roanna Ruiz reiterated a Buy rating on ARS Pharmaceuticals (SPRY - Research Report) on June 20 and set a price target of $13.00. The company's shares closed yesterday at $6.35.According to TipRanks, Ruiz is an analyst with an average return of -8.7% and a 41.98% success rate. Ruiz covers the Healthcare sector, focusing on ...Complete ARS Pharmaceuticals Inc. stock information by Barron's. View real-time SPRY stock price and news, along with industry-best analysis. Dec 6, 2021 · Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements. Close Trending Tickers bar 2 days ago · Check Out Our Latest Stock Report on SPRY ARS Pharmaceuticals Stock Up 1.1 %. Shares of NASDAQ:SPRY traded up $0.08 during trading on Wednesday, hitting $7.43. 103,051 shares of the company traded hands, compared to its average volume of 802,477. The business's fifty day moving average is $6.98 and its 200-day moving average is $7.02. flubber movie SPRY Stock Analysis: Fluctuations, Market Cap, and Earnings Growth in the Health Technology Sector The market cap of SPRY is $599.3M, indicating that it is a mid-cap company. The company’s earnings growth rate over the past year was 66.12%, while this year’s earnings growth rate is 21.84%.2 days ago · Price Performance Review of SPRY. On Tuesday, ARS Pharmaceuticals Inc. [NASDAQ:SPRY] saw its stock fall -1.74% to $7.35. On the same session, the stock had its day’s lowest price of $7.31, but rose to a high of $7.54. Over the last five days, the stock has gained 3.81%. ARS Pharmaceuticals Inc. shares have fallen nearly -13.83% since the year ... SPRY Overview Stock Screener Earnings Calendar Sectors Nasdaq | SPRY U.S.: Nasdaq ARS Pharmaceuticals Inc. Watch list Open Last Updated: Sep 1, 2023 11:23 a.m. EDT Real time quote $ 7.65 0.56...Sep 8, 2023 · Based on short-term price targets offered by two analysts, the average price target for ARS Pharmaceuticals, Inc. comes to $14.00. The forecasts range from a low of $13.00 to a high of $15.00. The ... boston to washington dc View ARS Pharmaceuticals, Inc SPRY investment & stock information. Get the latest ARS Pharmaceuticals, Inc SPRY detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.Wedbush Trims ARS Pharmaceuticals' PT to $15 From $17, Adjusts US, EU Launch Estimates, Lowers Peak Penetration for neffy/Anaphylaxis in US; Keeps Outperform Rating. Jun. 21. MT. Wedbush Initiates ARS Pharmaceuticals at Outperform With $10 PT, Says Neffy Intranasal Spray Set to Shake Up Epinephrine Market. Jan. 31. Dec 6, 2021 · Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements. Close Trending Tickers bar SPRY Earnings Date and Information. ARS Pharmaceuticals last released its quarterly earnings results on August 10th, 2023. The reported ($0.18) EPS for the quarter, missing analysts' consensus estimates of ($0.17) by $0.01. The business earned $0.01 million during the quarter.2 days ago · See the latest ARS Pharmaceuticals Inc stock price (NASDAQ:SPRY), related news, valuation, dividends and more to help you make your investing decisions. Nov 8, 2022 · This follows the satisfaction of all customary closing conditions, including approval of the merger by the stockholders of Silverback. The combined company will operate as ARS Pharmaceuticals, Inc., and shares of its common stock will commence trading under the trading symbol “SPRY” on November 9, 2022, on the Nasdaq Global Select Market. Find the latest SPDR S&P 500 ETF Trust (SPY) stock quote, history, news and other vital information to help you with your stock trading and investing.Sep 1, 2023 · ARS Pharmaceuticals GAAP EPS of -$0.87 beats by $0.45, revenue of $1.32M beats by $0.05M. SA NewsThu, Mar. 23. ARS Pharmaceuticals Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time SPRY stock price. kenoza hall Aug 31, 2023 · Analyzing SPRY Stock Performance. On Wednesday, ARS Pharmaceuticals Inc. [NASDAQ: SPRY] rose 0.28% to $7.11. The stock’s lowest price that day was $7.00, but it reached a high of $7.235 in the same session. During the last five days, there has been a surge of approximately 1.72%. Jun 23, 2023 · Analysts have varying views on the stock, with 3 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 as “hold,” and 0 as “sell.” The average price suggested by analysts for SPRY is $15.67, which is $9.08 above the current market price. The pu May 9, 2023 · On May 9, 2023, SPRY stock had a median target price of $17.00, representing a significant increase of 227.87% from the last price of $5.19. The current consensus among three polled investment analysts is to buy stock in ARS Pharmaceuticals Inc. The earnings per share for SPRY stock were -$0.16, and the sales were $0.00 for the current quarter. SVB Securities analyst Roanna Ruiz reiterated a Buy rating on ARS Pharmaceuticals (SPRY - Research Report) on June 20 and set a price target of $13.00. The company's shares closed yesterday at $6.35.According to TipRanks, Ruiz is an analyst with an average return of -8.7% and a 41.98% success rate. Ruiz covers the Healthcare sector, focusing on ...The FDA's Pulmonary-Allergy Drug Advisory Committee voted 16-6 in favor of ARS Pharmaceuticals Inc's. SPRY. neffy in treating severe allergic reactions for adults (and 16-5 for children who weigh ... ghost whisperer Silverback Therapeutics News: This is the News-site for the company Silverback Therapeutics on Markets Insider SPYR, Inc. is a holding company, which engages in the development and resell of Apple compatible products with an emphasis on the smart home market. It also identifies and acquires companies ... ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops treatments for patients and parents affected by severe allergic reactions. It is developing neffy, a needle-free and low-dose intranasal epinephrine nasal spray for patients and their caregivers with type I allergic reactions, including anaphylaxis.2 days ago · See the latest ARS Pharmaceuticals Inc stock price (NASDAQ:SPRY), related news, valuation, dividends and more to help you make your investing decisions. lee's liquor Find the latest SPDR S&P 500 ETF Trust (SPY) stock quote, history, news and other vital information to help you with your stock trading and investing.The Competitors page allows you to view information for other symbols found in the same sector. In the table, you'll find all the components (individual stock symbols) found in that sector, ranking them by their Weighted Alpha (a rating of growth patterns in a one-year period). Weighted Alpha is a measure of how much a stock has risen or fallen ... 2 days ago · See the latest ARS Pharmaceuticals Inc stock price (NASDAQ:SPRY), related news, valuation, dividends and more to help you make your investing decisions. 60-Month Beta: Coefficient that measures the volatility of a stock's returns relative to the market (S&P 500). It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share.May 8, 2023 · As of May 08, 2023, 4:00 PM CST, ARS Pharmaceuticals Inc’s stock price was $6.01. ARS Pharmaceuticals Inc is down 4.75% from its previous closing price of $6.31. During the last market session, ARS Pharmaceuticals Inc’s stock traded between $6.09 and $6.44. Currently, there are 54.08 million shares of ARS Pharmaceuticals Inc stock available ... The FDA's Pulmonary-Allergy Drug Advisory Committee voted 16-6 in favor of ARS Pharmaceuticals Inc's. SPRY. neffy in treating severe allergic reactions for adults (and 16-5 for children who weigh ...Complete ARS Pharmaceuticals Inc. stock information by Barron's. View real-time SPRY stock price and news, along with industry-best analysis.Sep 8, 2023 · Based on short-term price targets offered by two analysts, the average price target for ARS Pharmaceuticals, Inc. comes to $14.00. The forecasts range from a low of $13.00 to a high of $15.00. The ... Aug 31, 2023 · According to 3 analysts, the average rating for SPRY stock is "Buy." The 12-month stock price forecast is $14.5, which is an increase of 96.74% from the latest price. ARS Pharmaceuticals Inc. (NASDAQ:SPRY) price on Friday, September 01, rose 0.28% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $7.11. A look at the stock’s price movement, the close in the last trading session was $7.09, moving within a range at $7.09 and $8.00. Turning to its 52-week ...Discover historical prices for SPRY stock on Yahoo Finance. View daily, weekly or monthly format back to when ARS Pharmaceuticals, Inc. stock was issued. ... ARS Pharmaceuticals, Inc. (SPRY ... May 10, 2023 · SPRY Stock Analysis: Fluctuations, Market Cap, and Earnings Growth in the Health Technology Sector The market cap of SPRY is $599.3M, indicating that it is a mid-cap company. The company’s earnings growth rate over the past year was 66.12%, while this year’s earnings growth rate is 21.84%. ARS Pharma's $750 million market capitalization might be undervalued considering the size of the potential market for Neffy if approved by the FDA, making SPRY stock an enticing investment ... pato donald See the latest ARS Pharmaceuticals Inc stock price (NASDAQ:SPRY), related news, valuation, dividends and more to help you make your investing decisions.SPRY support price is $6.65 and resistance is $7.15 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SPRY stock will trade within this expected range on the day.Find the latest ARS Pharmaceuticals, Inc. (SPRY) stock quote, history, news and other vital information to help you with your stock trading and investing.Find the latest SPDR S&P 500 ETF Trust (SPY) stock quote, history, news and other vital information to help you with your stock trading and investing.Sep 6, 2023 · Price Target. $15.33. Profile Analyst Ratings Chart Competitors Earnings Financials Insider Trades Institutional Ownership Headlines Options Chain SEC Filings Short Interest Social Media. Current. Insider Ownership. Percentage. 35.60%. Number Of. SPRY support price is $6.65 and resistance is $7.15 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SPRY stock will trade within this expected range on the day. ARS Pharmaceuticals, Inc. Common Stock (SPRY) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.ARS Pharma's $750 million market capitalization might be undervalued considering the size of the potential market for Neffy if approved by the FDA, making SPRY stock an enticing investment ...Nov 8, 2022 · This follows the satisfaction of all customary closing conditions, including approval of the merger by the stockholders of Silverback. The combined company will operate as ARS Pharmaceuticals, Inc., and shares of its common stock will commence trading under the trading symbol “SPRY” on November 9, 2022, on the Nasdaq Global Select Market. envio de dinero cerca de mi Sep 1, 2023 · After registering a 10.16% upside in the latest session, ARS Pharmaceuticals Inc. (SPRY) has traded red over the past five days. The stock hit a weekly high of 8.00 this Thursday, 08/31/23, jumping 10.16% in its intraday price action. The 5-day price performance for the stock is 12.54%, and 11.57% over 30 days. ARS Pharmaceuticals, Inc. Common Stock (SPRY) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Find the latest SPYR, Inc. (SPYR) stock quote, history, news and other vital information to help you with your stock trading and investing.Aug 24, 2023 · The latest price target for ARS Pharmaceuticals ( NASDAQ: SPRY) was reported by Wedbush on Monday, August 14, 2023. The analyst firm set a price target for 15.00 expecting SPRY to rise to within ... Nov 8, 2022 · This follows the satisfaction of all customary closing conditions, including approval of the merger by the stockholders of Silverback. The combined company will operate as ARS Pharmaceuticals, Inc., and shares of its common stock will commence trading under the trading symbol “SPRY” on November 9, 2022, on the Nasdaq Global Select Market. Find the latest SPYR, Inc. (SPYR) stock quote, history, news and other vital information to help you with your stock trading and investing.XLEAR SINUS CARE. Working with your body to relieve sinus discomfort and help you breathe better. Inhibits germs and contaminants from sticking to the nose and sinuses through natural xylitol. Reduces swelling and opens the airway through a hypertonic solution. Cleanses and hydrates with a simple solution any person can enjoy. Market Capitalization. $704.35 million. P/E Ratio. N/A. Dividend Yield. N/A. Price Target. $15.33. Profile Analyst Ratings Chart Competitors Earnings Financials Insider Trades Institutional Ownership Headlines Options Chain SEC Filings Short Interest Social Media.SPRY Stock Analysis Overview What this means: Ars Pharmaceuticals Inc (SPRY) gets an Overall Rank of 67, which is an above average rank under InvestorsObserver's stock ranking system. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value.ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops treatments for patients and parents affected by severe allergic reactions. It is developing neffy, a needle-free and low-dose intranasal epinephrine nasal spray for patients and their caregivers with type I allergic reactions, including anaphylaxis.SPRY, The start of multi day / week breakout has commenced. SPRY has gained +77.88% last trading day due to FDA conveying benefits of their epinephrine nasal spray -- and a possible commercial approval on a scheduled date. Investors confidence were UP reflecting the massive price surge last May 11. Nov 8, 2022 · This follows the satisfaction of all customary closing conditions, including approval of the merger by the stockholders of Silverback. The combined company will operate as ARS Pharmaceuticals, Inc., and shares of its common stock will commence trading under the trading symbol “SPRY” on November 9, 2022, on the Nasdaq Global Select Market. Insiders own 34% of ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) shares but individual investors control 36% of the company. (Simply Wall St.) Nov-10-22 08:00AM. ARS Pharmaceuticals Announces Presentation of Clinical Data Supporting neffy® (epinephrine nasal spray) for the Treatment of Allergic Reactions (Type I) including Anaphylaxis.ARS is currently developing a needle-free nasal spray designed to consistently deliver a pharmacodynamic exposure of epinephrine that is similar to existing treatments. Our nasal spray may help reduce hesitation and allow patients to confidently administer when needed. Patient and Caregiver preparedness to act quickly and confidently during a ...2 days ago · See the latest ARS Pharmaceuticals Inc stock price (NASDAQ:SPRY), related news, valuation, dividends and more to help you make your investing decisions. wilson's garden center Sep 1, 2023 · ARS Pharmaceuticals GAAP EPS of -$0.87 beats by $0.45, revenue of $1.32M beats by $0.05M. SA NewsThu, Mar. 23. Feb 22, 2023 · Mar 23, 2023. ARS Pharmaceuticals Highlights Progress and Reports Fourth Quarter and Full Year 2022 Financial Results. Feb 23, 2023. ARS Pharmaceuticals Announces Presentation of Data Supporting neffy (epinephrine nasal spray) and Real-World Burden of Needle Injectors. Feb 22, 2023. Apr 4, 2023 · As of April 04, 2023, 4:00 PM CST, ARS Pharmaceuticals Inc’s stock price was $5.88. ARS Pharmaceuticals Inc is down 7.11% from its previous closing price of $6.33. During the last market session, ARS Pharmaceuticals Inc’s stock traded between $6.29 and $6.67. Currently, there are 54.08 million shares of ARS Pharmaceuticals Inc stock ... SPYR, Inc. is a holding company, which engages in the development and resell of Apple compatible products with an emphasis on the smart home market. It also identifies and acquires companies ... SPRY Earnings Date and Information. ARS Pharmaceuticals last released its quarterly earnings results on August 10th, 2023. The reported ($0.18) EPS for the quarter, missing analysts' consensus estimates of ($0.17) by $0.01. The business earned $0.01 million during the quarter.SPRY Overview Stock Screener Earnings Calendar Sectors Nasdaq | SPRY U.S.: Nasdaq ARS Pharmaceuticals Inc. Watch list Open Last Updated: Sep 1, 2023 11:23 a.m. EDT Real time quote $ 7.65 0.56... surah yasin Sep 8, 2023 · View ARS Pharmaceuticals, Inc SPRY investment & stock information. Get the latest ARS Pharmaceuticals, Inc SPRY detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Corporate insiders are often awarded stock options as part of their compensation packages; this gives them the right to buy shares at a set price for a finite period. When an insider buys stocks because they are receiving a grant of shares for retention purposes, the Buy does not reveal what they think about the company’s prospects. Nov 22, 2022 · As of 2023 July 13, Thursday current price of SPRY stock is 6.680$ and our data indicates that the asset price has been in an uptrend for the past 1 year (or since its inception). ARS Pharmaceuticals stock price as been showing a rising tendency so we believe that similar market segments were very popular in the given time frame. Nov 22, 2022 · As of 2023 July 13, Thursday current price of SPRY stock is 6.680$ and our data indicates that the asset price has been in an uptrend for the past 1 year (or since its inception). ARS Pharmaceuticals stock price as been showing a rising tendency so we believe that similar market segments were very popular in the given time frame. Find the latest SPDR S&P 500 ETF Trust (SPY) stock quote, history, news and other vital information to help you with your stock trading and investing.Get the latest ARS Pharmaceuticals Inc (SPRY) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.XLEAR SINUS CARE. Working with your body to relieve sinus discomfort and help you breathe better. Inhibits germs and contaminants from sticking to the nose and sinuses through natural xylitol. Reduces swelling and opens the airway through a hypertonic solution. Cleanses and hydrates with a simple solution any person can enjoy. zion mart Latest ARS Pharmaceuticals Inc Stock News. As of September 01, 2023, ARS Pharmaceuticals Inc had a $677.6 million market capitalization, putting it in the 59th percentile of companies in the Biotechnology & Medical Research industry. ARS Pharmaceuticals Inc does not have a meaningful P/E due to negative earnings over the last 12 trailing months.Sep 1, 2023 · Latest ARS Pharmaceuticals Inc Stock News. As of September 01, 2023, ARS Pharmaceuticals Inc had a $677.6 million market capitalization, putting it in the 59th percentile of companies in the Biotechnology & Medical Research industry. ARS Pharmaceuticals Inc does not have a meaningful P/E due to negative earnings over the last 12 trailing months. Sep 6, 2023 · Price Target. $15.33. Profile Analyst Ratings Chart Competitors Earnings Financials Insider Trades Institutional Ownership Headlines Options Chain SEC Filings Short Interest Social Media. Current. Insider Ownership. Percentage. 35.60%. Number Of. According to our current SPRY stock forecast, the value of ARS Pharmaceuticals, Inc. shares will drop by -0.06% and reach $ 7.07 per share by September 5, 2023. According to our technical indicators, the current sentiment is Bearish while the Fear & Greed Index is showing 39 (Fear).Sep 12, 2023 · SPRY Overview Stock Screener Earnings Calendar Sectors Nasdaq | SPRY U.S.: Nasdaq ARS Pharmaceuticals Inc. Watch list Open Last Updated: Sep 1, 2023 11:23 a.m. EDT Real time quote $ 7.65 0.56... This follows the satisfaction of all customary closing conditions, including approval of the merger by the stockholders of Silverback. The combined company will operate as ARS Pharmaceuticals, Inc., and shares of its common stock will commence trading under the trading symbol “SPRY” on November 9, 2022, on the Nasdaq Global Select Market. cast of the movie speed ARS Pharmaceuticals, Inc. (SPRY) NasdaqGM - NasdaqGM Real Time Price. Currency in USD. Follow. 7.37 +0.05 (+0.68%) At close: 04:00PM EDT. 7.45 +0.08 (+1.09%) After hours: 06:33PM EDT. 1d.Get the latest ARS Pharmaceuticals Inc (SPRY) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Complete ARS Pharmaceuticals Inc. stock information by Barron's. View real-time SPRY stock price and news, along with industry-best analysis.ARS Pharmaceuticals Inc will merge with Silverback Therapeutics Inc (NASDAQ: SBTX) in an all-stock transaction, with a new entity operating under the ARS Pharmaceuticals name and trade on NASDAQ ...Silverback Therapeutics News: This is the News-site for the company Silverback Therapeutics on Markets Insider party fowl ARS Pharmaceuticals GAAP EPS of -$0.87 beats by $0.45, revenue of $1.32M beats by $0.05M. SA NewsThu, Mar. 23.On May 9, 2023, SPRY stock had a median target price of $17.00, representing a significant increase of 227.87% from the last price of $5.19. The current consensus among three polled investment analysts is to buy stock in ARS Pharmaceuticals Inc. The earnings per share for SPRY stock were -$0.16, and the sales were $0.00 for the current quarter.Latest ARS Pharmaceuticals Inc Stock News. As of September 01, 2023, ARS Pharmaceuticals Inc had a $677.6 million market capitalization, putting it in the 59th percentile of companies in the Biotechnology & Medical Research industry. ARS Pharmaceuticals Inc does not have a meaningful P/E due to negative earnings over the last 12 trailing months. drill master May 15, 2023 · ARS Pharma's $750 million market capitalization might be undervalued considering the size of the potential market for Neffy if approved by the FDA, making SPRY stock an enticing investment ... The AAII Stock Evaluator puts a company’s grades, charts, news, financials, valuation, ratios, filings and more at your fingertips. ARS Pharmaceuticals Inc’s Stock Price as of Market Close. As of May 04, 2023, 4:00 PM CST, ARS Pharmaceuticals Inc’s stock price was $6.12.Aug 24, 2023 · The latest price target for ARS Pharmaceuticals ( NASDAQ: SPRY) was reported by Wedbush on Monday, August 14, 2023. The analyst firm set a price target for 15.00 expecting SPRY to rise to within ... Browse 10+ constance spry stock photos and images available, or start a new search to explore more stock photos and images. Sort by: Most popular. 2 days ago · Complete ARS Pharmaceuticals Inc. stock information by Barron's. View real-time SPRY stock price and news, along with industry-best analysis. Find the latest Ocean Spray Cranberries, Inc. PFD 4% (OCESP) stock quote, history, news and other vital information to help you with your stock trading and investing.Price Performance Review of SPRY. On Friday, ARS Pharmaceuticals Inc. [NASDAQ:SPRY] saw its stock fall -0.29% to $6.83. On the same session, the stock had its day’s lowest price of $6.51, but rose to a high of $7.08. Over the last five days, the stock has lost -2.84%. ARS Pharmaceuticals Inc. shares have fallen nearly -19.93% since the year ...ARS is currently developing a needle-free nasal spray designed to consistently deliver a pharmacodynamic exposure of epinephrine that is similar to existing treatments. Our nasal spray may help reduce hesitation and allow patients to confidently administer when needed. Patient and Caregiver preparedness to act quickly and confidently during a ... screencastify extension Get the latest ARS Pharmaceuticals Inc (SPRY) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Complete ARS Pharmaceuticals Inc. stock information by Barron's. View real-time SPRY stock price and news, along with industry-best analysis.ARS Pharmaceuticals GAAP EPS of -$0.87 beats by $0.45, revenue of $1.32M beats by $0.05M. SA NewsThu, Mar. 23.Track ARS Pharmaceuticals Inc (SPRY) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsApr 4, 2023 · As of April 04, 2023, 4:00 PM CST, ARS Pharmaceuticals Inc’s stock price was $5.88. ARS Pharmaceuticals Inc is down 7.11% from its previous closing price of $6.33. During the last market session, ARS Pharmaceuticals Inc’s stock traded between $6.29 and $6.67. Currently, there are 54.08 million shares of ARS Pharmaceuticals Inc stock ... montmorency Sep 12, 2023 · SPRY Overview Stock Screener Earnings Calendar Sectors Nasdaq | SPRY U.S.: Nasdaq ARS Pharmaceuticals Inc. Watch list Open Last Updated: Sep 1, 2023 11:23 a.m. EDT Real time quote $ 7.65 0.56... Feb 16, 2023 · Past Events. SVB Securities Virtual Global Biopharma Conference 2023. Feb 16, 2023 at 2:20 PM EST. Find the latest ARS Pharmaceuticals, Inc. (SPRY) stock quote, history, news and other vital information to help you with your stock trading and investing. Ars Pharmaceuticals stock was originally listed at a price of $25.00 in Dec 4, 2020. If you had invested in Ars Pharmaceuticals stock at $25.00, your return over the last 2 years would have been -71.56%, for an annualized return of -46.67% (not including any dividends or dividend reinvestments). How much is Ars Pharmaceuticals's stock price per ...May 15, 2023 · ARS Pharma's $750 million market capitalization might be undervalued considering the size of the potential market for Neffy if approved by the FDA, making SPRY stock an enticing investment ... facebook guest May 15, 2023 · ARS Pharma's $750 million market capitalization might be undervalued considering the size of the potential market for Neffy if approved by the FDA, making SPRY stock an enticing investment ... Sep 6, 2023 · Price Target. $15.33. Profile Analyst Ratings Chart Competitors Earnings Financials Insider Trades Institutional Ownership Headlines Options Chain SEC Filings Short Interest Social Media. Current. Insider Ownership. Percentage. 35.60%. Number Of. May 8, 2023 · As of May 08, 2023, 4:00 PM CST, ARS Pharmaceuticals Inc’s stock price was $6.01. ARS Pharmaceuticals Inc is down 4.75% from its previous closing price of $6.31. During the last market session, ARS Pharmaceuticals Inc’s stock traded between $6.09 and $6.44. Currently, there are 54.08 million shares of ARS Pharmaceuticals Inc stock available ... The FDA's Pulmonary-Allergy Drug Advisory Committee voted 16-6 in favor of ARS Pharmaceuticals Inc's. SPRY. neffy in treating severe allergic reactions for adults (and 16-5 for children who weigh ...Jun 23, 2023 · Analysts have varying views on the stock, with 3 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 as “hold,” and 0 as “sell.” The average price suggested by analysts for SPRY is $15.67, which is $9.08 above the current market price. The pu Nov 15, 2022 · 60-Month Beta: Coefficient that measures the volatility of a stock's returns relative to the market (S&P 500). It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops treatments for patients and parents affected by severe allergic reactions. It is developing neffy, a needle-free and low-dose intranasal epinephrine nasal spray for patients and their caregivers with type I allergic reactions, including anaphylaxis.ARS Pharmaceuticals, Inc. (SPRY) NasdaqGM - NasdaqGM Real Time Price. Currency in USD. Follow. 7.00 +0.09 (+1.38%) At close: 04:00PM EDT. 7.00 0.00 (0.00%) After hours: 05:00PM EDT. 1d.SVB Securities analyst Roanna Ruiz reiterated a Buy rating on ARS Pharmaceuticals (SPRY - Research Report) on June 20 and set a price target of $13.00. The company's shares closed yesterday at $6.35.According to TipRanks, Ruiz is an analyst with an average return of -8.7% and a 41.98% success rate. Ruiz covers the Healthcare sector, focusing on ... katv 7 ARS Pharmaceuticals Inc will merge with Silverback Therapeutics Inc (NASDAQ: SBTX) in an all-stock transaction, with a new entity operating under the ARS Pharmaceuticals name and trade on NASDAQ ...SVB Securities analyst Roanna Ruiz reiterated a Buy rating on ARS Pharmaceuticals (SPRY - Research Report) on June 20 and set a price target of $13.00. The company's shares closed yesterday at $6.35.According to TipRanks, Ruiz is an analyst with an average return of -8.7% and a 41.98% success rate. Ruiz covers the Healthcare sector, focusing on ...2 days ago · See the latest ARS Pharmaceuticals Inc stock price (NASDAQ:SPRY), related news, valuation, dividends and more to help you make your investing decisions. The FDA's Pulmonary-Allergy Drug Advisory Committee voted 16-6 in favor of ARS Pharmaceuticals Inc's. SPRY. neffy in treating severe allergic reactions for adults (and 16-5 for children who weigh ... get fit Complete ARS Pharmaceuticals Inc. stock information by Barron's. View real-time SPRY stock price and news, along with industry-best analysis.Feb 22, 2023 · Mar 23, 2023. ARS Pharmaceuticals Highlights Progress and Reports Fourth Quarter and Full Year 2022 Financial Results. Feb 23, 2023. ARS Pharmaceuticals Announces Presentation of Data Supporting neffy (epinephrine nasal spray) and Real-World Burden of Needle Injectors. Feb 22, 2023.